10x Genomics Inc (LTS:0A88)
$ 14.72 0.6324 (4.47%) Market Cap: 1.78 Bil Enterprise Value: 1.46 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 60/100

Q3 2024 10X Genomics Inc Earnings Call Transcript

Oct 29, 2024 / 08:30PM GMT
Release Date Price: $15.79 (+0.19%)
Operator

Thank you for standing by. My name is Mark, and I will be your conference operator today. At this time, I would like to welcome everyone to the 10X Genomics Third Quarter 2024 Earnings Conference Call. Today's call is being recorded. (Operator Instructions)

I would now like to turn the call over to Cassie Corneau, Senior Director, Head of Investor Relations, and Strategic Finance. Cassie, please go ahead.

Cassie Corneau
10X Genomics Inc - Manager of IR and Strategic Finance

Thank you, and good afternoon, everyone. Earlier today, 10X Genomics released financial results for the third quarter ended September 30, 2024. If you have not received this news release, or if you would like to be added to the company's distribution list, please send an e-mail to investors@ 10X genomics.com. An archived webcast of this call will be available on the Investor tab of the company's website, 10X genomics.com for at least 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot